Inotropic modifiers primarily affect which aspect of cardiac performance?

Prepare for the NREMT Advanced-EMT Test. Use flashcards and multiple choice questions, complete with hints and explanations. Ready yourself for success on your exam!

Multiple Choice

Inotropic modifiers primarily affect which aspect of cardiac performance?

Explanation:
Inotropic modifiers change the strength of the heart’s contraction (contractility). By increasing or decreasing how forcefully the ventricles squeeze, they directly alter the amount of blood ejected with each beat—stroke volume. This is why these drugs influence cardiac output through changes in stroke volume, not by changing how quickly electrical impulses travel through the heart. Conduction velocity is governed by the heart’s electrical system and autonomic influences, not by contractility. They also don’t fix valvular problems, which are structural issues with the valves. So, the primary effect of inotropic modifiers is on contractility, which translates to changes in stroke volume.

Inotropic modifiers change the strength of the heart’s contraction (contractility). By increasing or decreasing how forcefully the ventricles squeeze, they directly alter the amount of blood ejected with each beat—stroke volume. This is why these drugs influence cardiac output through changes in stroke volume, not by changing how quickly electrical impulses travel through the heart. Conduction velocity is governed by the heart’s electrical system and autonomic influences, not by contractility. They also don’t fix valvular problems, which are structural issues with the valves. So, the primary effect of inotropic modifiers is on contractility, which translates to changes in stroke volume.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy